Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 370Head and Neck Neoplasms 356Nasopharyngeal Carcinoma 140Thyroid Neoplasms 124Carcinoma, Non-Small-Cell Lung 93Mouth Neoplasms 84Melanoma 76Breast Neoplasms 75Oropharyngeal Neoplasms 72Colorectal Neoplasms 68Uterine Cervical Neoplasms 66Lung Neoplasms 66Neoplasms 63Ovarian Neoplasms 61Neoplasm Metastasis 52Prostatic Neoplasms 51Stomach Neoplasms 49Pancreatic Neoplasms 47Carcinoma, Squamous Cell 45Triple Negative Breast Neoplasms 43Laryngeal Neoplasms 42Esophageal Neoplasms 42Endometrial Neoplasms 42Thyroid Nodule 37Carcinoma, Renal Cell 37Urinary Bladder Neoplasms 36Sarcoma 34Recurrence 31Carcinoma 30Nasopharyngeal Neoplasms 28

Interventions

Thyrotropin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Recombinant Human Thyroid Stimulating Hormone × Head & Neck × Clear all
NCT06431620 2024-05-28

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

Nanjing First Hospital, Nanjing Medical University

Phase NA Recruiting
15 enrolled
Head & Neck

Recombinant Human Thyroid Stimulating Hormone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡